Aignostics Launches HETA Clinical, a New Family of AI Products that Speed Up Pathology Workflows and Reduce Failed Molecular Tests
<p>BERLIN and NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Today, Aignostics announced the launch of HETA Clinical, a new family of pan-cancer AI products spanning the pathology workflow from intake and evaluation to molecular testing. The first four HETA Clinical products measure slide quality,...</p>
Read original article ↗
Related Articles
Hard science data is typically no barrier to enduring belief for the conspiracy theorist. Nevertheless, this engineer tr
Withings BodyScan 2 Named One of TIME's Best Inventions of 2026
The world's first longevity station is honored for turning the daily weigh in into a complete view of cardiometabolic he
Surface Laptop Ultra review: a different kind of MacBook Pro
This MacBook Pro lookalike is designed for developers. After setting up Microsoft's Surface Laptop Ultra, I spent five